Necrotizing fasciitis is diagnosed primarily through clinical assessment, not a single definitive test. Because the infection destroys tissue along the fascia (the connective layer beneath the skin) rather than the skin itself, early signs can look deceptively similar to cellulitis or other common skin infections. The most reliable early clue is pain that seems far worse than the visible skin changes would explain. When suspicion is high, surgery to directly inspect the tissue remains the gold standard for confirmation.
Why It’s So Hard to Catch Early
The infection starts in the deepest layers of skin and the superficial fascia, while the outer skin layers remain initially unaffected. This means the surface can look like an ordinary skin infection, with localized swelling, redness, and warmth, while destruction is already spreading underneath. Bacteria produce enzymes that break down fat and fascia directly, and the fascia’s limited blood supply makes it harder for the immune system to respond. That combination allows the infection to move fast while looking relatively mild on the outside.
The overlap with cellulitis is where misdiagnosis happens most often. Both start with redness, swelling, and pain. The critical differences: necrotizing fasciitis tends to progress rapidly over hours rather than days, produces pain that seems wildly out of proportion to what’s visible, and often causes systemic symptoms like fever and a general sense of being very unwell. Subcutaneous crepitus, a crackling sensation under the skin caused by gas-producing bacteria, can sometimes be felt on exam, though it isn’t always present.
The Key Clinical Signs
Early symptoms include a red, warm, or swollen area of skin that spreads quickly, fever, and severe pain that extends beyond the visibly affected area. That last feature, often called “pain out of proportion to exam findings,” is the single most important clinical warning sign. A patient with what looks like a modest patch of redness but who is in agonizing pain should raise immediate concern.
As the infection progresses, the skin may change color, turning dusky, purple, or gray. Blisters or bullae can form. The area may become numb as nerves in the fascia are destroyed, which can paradoxically make the patient seem to improve right before things get much worse. A serum lactate level above 2.0 mmol/L at presentation is another clinical indicator that points toward necrotizing fasciitis rather than a simpler soft tissue infection.
Blood Tests and the LRINEC Score
A scoring system called the Laboratory Risk Indicator for Necrotizing Fasciitis (LRINEC) was developed to help distinguish necrotizing fasciitis from other soft tissue infections using six routine blood tests. It assigns points based on C-reactive protein (a marker of inflammation), white blood cell count, hemoglobin, sodium, creatinine, and glucose. A score of 8 or higher correlates with roughly a 75% chance of necrotizing fasciitis being present.
The score’s strength is its negative predictive value: in the original study, a low score was 96% accurate at ruling the diagnosis out. But subsequent evaluations have found it lacks the sensitivity to reliably catch all cases. In practice, this means a high LRINEC score should accelerate the diagnostic workup, but a low score should never be used to dismiss the diagnosis if the clinical picture is concerning. Pain out of proportion, rapidly spreading infection, and systemic illness still override a reassuring lab panel.
What Imaging Can and Can’t Show
CT scanning is the primary imaging tool for evaluating suspected necrotizing fasciitis because it’s fast and widely available. The hallmark finding is gas tracking along the fascia and within fluid collections in the deep tissue planes. In one study of 20 consecutive patients, CT revealed fascial thickening and fat stranding in 80% of cases, soft tissue gas in 55%, and abscesses in 35%. Thickening of the fascia that fails to enhance with contrast dye helps distinguish necrotizing fasciitis from non-necrotizing infections.
The problem is that many of these findings, particularly fat stranding and increased tissue density, also show up in ordinary cellulitis. And the absence of gas does not rule out necrotizing fasciitis. Some bacterial types, particularly group A streptococcus acting alone, produce little or no gas. So a CT scan that looks relatively benign can still be hiding a necrotizing infection underneath.
MRI offers better soft tissue contrast and can detect fascial inflammation earlier, but it takes longer to perform and is often impractical in an emergency. Bedside ultrasound is a faster alternative that can identify fascial thickening, abnormal fluid along the deep fascia, and subcutaneous air. One study reported 88% sensitivity and 93% specificity for soft tissue infections using ultrasound. However, its accuracy varies depending on the location and depth of the infection, and it cannot safely rule out the diagnosis on its own. The World Society of Emergency Surgery recommends ultrasound specifically for unstable patients when CT isn’t feasible.
The Finger Test: Bedside Confirmation
When clinical suspicion is strong but imaging is inconclusive, a procedure called the “finger test” can be performed at the bedside under local anesthesia. A small incision is made down to the fascia, and a gloved finger is inserted to probe the tissue. In necrotizing fasciitis, the tissue offers no resistance to blunt dissection, meaning the finger slides easily along planes that would normally hold firm. Other telltale signs include a complete lack of bleeding from the incision site, foul-smelling grayish fluid (sometimes described as “dishwater pus”), and muscles that don’t contract when touched.
This test is quick and can be done in the emergency department. It essentially serves as a bridge between clinical suspicion and full surgical exploration, giving the surgical team enough information to proceed to the operating room without waiting for more imaging or lab results.
Surgical Exploration as the Gold Standard
Definitive diagnosis happens in the operating room. During surgical exploration, the surgeon directly visualizes the fascia and surrounding tissue, looking for the same signs found during the finger test on a larger scale: necrotic (dead) fascia, lack of bleeding, foul-smelling fluid, and tissue that falls apart with minimal manipulation. Tissue samples are sent for both pathology and microbiology to confirm the diagnosis and identify the specific bacteria involved.
The microbiology matters for treatment. Roughly half of cases are Type I (polymicrobial), involving a mix of bacteria including streptococci, staphylococci, gut bacteria, and anaerobes. About a third are Type II, caused by group A streptococcus alone or with staphylococci. Type II infections are particularly tricky to diagnose early because they often lack the foul-smelling discharge associated with anaerobic bacteria. When anaerobic bacteria are identified in cultures, more aggressive follow-up surgery tends to be needed.
Why Speed Matters More Than Precision
A major meta-analysis pooling data from multiple studies found that surgical treatment within 6 hours of hospital presentation carried a 19% mortality rate, compared to 32% when surgery was delayed beyond 6 hours. Surgery within 12 hours showed 19% mortality versus 34% after 12 hours. Every hour spent chasing a more certain diagnosis is time the infection uses to spread.
This is why clinical guidelines from the World Society of Emergency Surgery recommend that any rapidly progressive soft tissue infection should be treated aggressively as a necrotizing infection until proven otherwise. The diagnostic process for necrotizing fasciitis is not a stepwise algorithm where you complete one test before ordering the next. It’s a parallel process: blood work, imaging, and surgical consultation should all happen simultaneously. If the clinical picture is convincing, surgery should not wait for CT results or a completed LRINEC score. The cost of operating on a patient who turns out to have severe cellulitis is far lower than the cost of delaying surgery on a patient with necrotizing fasciitis.